X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Lupin Ltd with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs TEVA PHARMA (Israel) - Comparison Results

LUPIN    Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 LUPIN   TEVA PHARMA
EQUITY SHARE DATA
    LUPIN
Mar-18
TEVA PHARMA
Dec-13
LUPIN/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,4652,897-   
Low Rs7272,517-   
Sales per share (Unadj.) Rs349.61,662.7-  
Earnings per share (Unadj.) Rs5.6103.9-  
Cash flow per share (Unadj.) Rs29.6238.3-  
Dividends per share (Unadj.) Rs5.0090.93-  
Dividend yield (eoy) %0.53.4 13.6%  
Book value per share (Unadj.) Rs300.31,847.0-  
Shares outstanding (eoy) m452.08848.00-   
Bonus/Rights/Conversions ESOPS--  
Price / Sales ratio x3.11.6 192.6%   
Avg P/E ratio x197.226.1 756.7%  
P/CF ratio (eoy) x37.111.4 326.2%  
Price / Book Value ratio x3.61.5 249.0%  
Dividend payout %90.087.5 102.8%   
Avg Mkt Cap Rs m495,5022,295,528 21.6%   
No. of employees `00017.044.9 37.9%   
Total wages/salary Rs m28,6470-   
Avg. sales/employee Rs Th9,273.631,371.6 29.6%   
Avg. wages/employee Rs Th1,681.00-   
Avg. net profit/employee Rs Th147.41,959.8 7.5%   
INCOME DATA
Net Sales Rs m158,0421,409,995 11.2%  
Other income Rs m1,5040-   
Total revenues Rs m159,5451,409,995 11.3%   
Gross profit Rs m31,475386,128 8.2%  
Depreciation Rs m10,859113,971 9.5%   
Interest Rs m2,04427,695 7.4%   
Profit before tax Rs m20,076244,462 8.2%   
Minority Interest Rs m-711,111 -6.4%   
Prior Period Items Rs m350-   
Extraordinary Inc (Exp) Rs m-14,644-160,476 9.1%   
Tax Rs m2,885-2,985 -96.6%   
Profit after tax Rs m2,51388,081 2.9%  
Gross profit margin %19.927.4 72.7%  
Effective tax rate %14.4-1.2 -1,176.8%   
Net profit margin %1.66.2 25.4%  
BALANCE SHEET DATA
Current assets Rs m122,095952,305 12.8%   
Current liabilities Rs m50,956830,491 6.1%   
Net working cap to sales %45.08.6 521.0%  
Current ratio x2.41.1 209.0%  
Inventory Days Days8591 93.2%  
Debtors Days Days12096 125.0%  
Net fixed assets Rs m129,876460,535 28.2%   
Share capital Rs m9043,471 26.1%   
"Free" reserves Rs m134,8660-   
Net worth Rs m135,7711,566,237 8.7%   
Long term debt Rs m64,245720,962 8.9%   
Total assets Rs m263,0543,222,290 8.2%  
Interest coverage x10.89.8 110.2%   
Debt to equity ratio x0.50.5 102.8%  
Sales to assets ratio x0.60.4 137.3%   
Return on assets %1.73.6 48.2%  
Return on equity %1.95.6 32.9%  
Return on capital %3.74.9 75.4%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m33,8070-   
CASH FLOW
From Operations Rs m17,512224,680 7.8%  
From Investments Rs m-14,073-79,613 17.7%  
From Financial Activity Rs m-14,921-269,519 5.5%  
Net Cashflow Rs m-11,482-124,452 9.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 69.41 Rs / USD

Compare LUPIN With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare LUPIN With: FULFORD INDIA  CADILA HEALTHCARE  WYETH LTD  DIVIS LABORATORIES  J.B.CHEMICALS  



Today's Market

Sensex at New Highs, Jet Airways Suspends Operations - Your Inside Scoop of the Markets(Podcast)

Jet Airways, once India's largest private airline halted its operations indefinitely yesterday. The carrier flew its last scheduled flight from Amritsar to Mumbai yesterday.

Related Views On News

LUPIN LTD Announces Quarterly Results (3QFY19); Net Profit Down 149.7% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, LUPIN LTD has posted a net profit of Rs 2 bn (down 149.7% YoY). Sales on the other hand came in at Rs 45 bn (up 78.0% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD Announces Quarterly Results (2QFY19); Net Profit Down 31.1% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, LUPIN LTD has posted a net profit of Rs 3 bn (down 31.1% YoY). Sales on the other hand came in at Rs 40 bn (up 53.1% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of LUPIN LTD for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of LUPIN LTD. Also includes updates on the valuation of LUPIN LTD.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


Apr 18, 2019 (Close)

TRACK LUPIN

COMPARE LUPIN WITH

MARKET STATS